171 related articles for article (PubMed ID: 35659527)
1. Structures of tau and α-synuclein filaments from brains of patients with neurodegenerative diseases.
Kametani F; Hasegawa M
Neurochem Int; 2022 Sep; 158():105362. PubMed ID: 35659527
[TBL] [Abstract][Full Text] [Related]
2. Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43.
Tarutani A; Adachi T; Akatsu H; Hashizume Y; Hasegawa K; Saito Y; Robinson AC; Mann DMA; Yoshida M; Murayama S; Hasegawa M
Acta Neuropathol; 2022 Jun; 143(6):613-640. PubMed ID: 35513543
[TBL] [Abstract][Full Text] [Related]
3. Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term.
Rey NL; George S; Steiner JA; Madaj Z; Luk KC; Trojanowski JQ; Lee VM; Brundin P
Acta Neuropathol; 2018 Jan; 135(1):65-83. PubMed ID: 29209768
[TBL] [Abstract][Full Text] [Related]
4. Human tauopathy-derived tau strains determine the substrates recruited for templated amplification.
Tarutani A; Miyata H; Nonaka T; Hasegawa K; Yoshida M; Saito Y; Murayama S; Robinson AC; Mann DMA; Tomita T; Hasegawa M
Brain; 2021 Sep; 144(8):2333-2348. PubMed ID: 33693528
[TBL] [Abstract][Full Text] [Related]
5. More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases.
Lee VM; Giasson BI; Trojanowski JQ
Trends Neurosci; 2004 Mar; 27(3):129-34. PubMed ID: 15036877
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids.
Scheres SHW; Ryskeldi-Falcon B; Goedert M
Nature; 2023 Sep; 621(7980):701-710. PubMed ID: 37758888
[TBL] [Abstract][Full Text] [Related]
7. Alpha-synuclein and tau: teammates in neurodegeneration?
Moussaud S; Jones DR; Moussaud-Lamodière EL; Delenclos M; Ross OA; McLean PJ
Mol Neurodegener; 2014 Oct; 9():43. PubMed ID: 25352339
[TBL] [Abstract][Full Text] [Related]
8. Relationship Between Tau, β Amyloid and α-Synuclein Pathologies.
Walker L; Attems J
Adv Exp Med Biol; 2019; 1184():169-176. PubMed ID: 32096037
[TBL] [Abstract][Full Text] [Related]
9. Tau induces formation of α-synuclein filaments with distinct molecular conformations.
Hojjatian A; Dasari AKR; Sengupta U; Taylor D; Daneshparvar N; Yeganeh FA; Dillard L; Michael B; Griffin RG; Borgnia MJ; Kayed R; Taylor KA; Lim KH
Biochem Biophys Res Commun; 2021 May; 554():145-150. PubMed ID: 33798940
[TBL] [Abstract][Full Text] [Related]
10. Seeded assembly in vitro does not replicate the structures of α-synuclein filaments from multiple system atrophy.
Lövestam S; Schweighauser M; Matsubara T; Murayama S; Tomita T; Ando T; Hasegawa K; Yoshida M; Tarutani A; Hasegawa M; Goedert M; Scheres SHW
FEBS Open Bio; 2021 Apr; 11(4):999-1013. PubMed ID: 33548114
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of Cell-to-Cell Transmission of Pathological Tau: A Review.
Gibbons GS; Lee VMY; Trojanowski JQ
JAMA Neurol; 2019 Jan; 76(1):101-108. PubMed ID: 30193298
[TBL] [Abstract][Full Text] [Related]
12. Initiation and synergistic fibrillization of tau and alpha-synuclein.
Giasson BI; Forman MS; Higuchi M; Golbe LI; Graves CL; Kotzbauer PT; Trojanowski JQ; Lee VM
Science; 2003 Apr; 300(5619):636-40. PubMed ID: 12714745
[TBL] [Abstract][Full Text] [Related]
13. Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains.
Arakhamia T; Lee CE; Carlomagno Y; Duong DM; Kundinger SR; Wang K; Williams D; DeTure M; Dickson DW; Cook CN; Seyfried NT; Petrucelli L; Fitzpatrick AWP
Cell; 2020 Feb; 180(4):633-644.e12. PubMed ID: 32032505
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of the co-deposition of multiple pathological proteins in neurodegenerative diseases.
Nonaka T; Masuda-Suzukake M; Hasegawa M
Neuropathology; 2018 Feb; 38(1):64-71. PubMed ID: 28948653
[TBL] [Abstract][Full Text] [Related]
15. Cell-to-Cell Transmission of Tau and α-Synuclein.
Uemura N; Uemura MT; Luk KC; Lee VM; Trojanowski JQ
Trends Mol Med; 2020 Oct; 26(10):936-952. PubMed ID: 32371172
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and therapeutic targeting of pathological tau proteins in neurodegenerative disorders.
Sahara N; Higuchi M
FEBS Open Bio; 2024 Feb; 14(2):165-180. PubMed ID: 37746832
[TBL] [Abstract][Full Text] [Related]
17. Emerging Trends in Cryo-EM-based Structural Studies of Neuropathological Amyloids.
Mishra S
J Mol Biol; 2023 Dec; 435(24):168361. PubMed ID: 37949311
[TBL] [Abstract][Full Text] [Related]
18. The interaction of α-synuclein and Tau: A molecular conspiracy in neurodegeneration?
Yan X; Uronen RL; Huttunen HJ
Semin Cell Dev Biol; 2020 Mar; 99():55-64. PubMed ID: 29738880
[TBL] [Abstract][Full Text] [Related]
19. Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau
Stopschinski BE; Holmes BB; Miller GM; Manon VA; Vaquer-Alicea J; Prueitt WL; Hsieh-Wilson LC; Diamond MI
J Biol Chem; 2018 Jul; 293(27):10826-10840. PubMed ID: 29752409
[TBL] [Abstract][Full Text] [Related]
20. Molecular Mechanisms in the Pathogenesis of Alzheimer's disease and Tauopathies-Prion-Like Seeded Aggregation and Phosphorylation.
Hasegawa M
Biomolecules; 2016 Apr; 6(2):. PubMed ID: 27136595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
